Pharmala Biotech Holdings Inc. (CSE:MDMA)
0.1500
-0.0100 (-6.25%)
Jun 10, 2026, 3:15 PM EST
Pharmala Biotech Holdings Balance Sheet
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash & Equivalents | 0.11 | 0.04 | 0.42 | 0.2 | 0.85 | 2.47 |
Short-Term Investments | 0.46 | 0.92 | - | - | - | - |
Cash & Short-Term Investments | 0.58 | 0.96 | 0.42 | 0.2 | 0.85 | 2.47 |
Cash Growth | -61.75% | 129.07% | 115.02% | -77.11% | -65.53% | - |
Accounts Receivable | 0.38 | 0.02 | 0.16 | 0.12 | 0.02 | - |
Other Receivables | 0.03 | 0.04 | 0.05 | 0.1 | 0.03 | 0.06 |
Receivables | 0.42 | 0.06 | 0.21 | 0.22 | 0.05 | 0.06 |
Inventory | 0.39 | 0.37 | 0.35 | 0.12 | 0.12 | - |
Prepaid Expenses | 0 | 0.25 | 0.06 | 0.17 | 0.07 | - |
Total Current Assets | 1.39 | 1.65 | 1.04 | 0.71 | 1.09 | 2.53 |
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Other Intangible Assets | 1.74 | 1.77 | 1.85 | 1.7 | 1.24 | 0.26 |
Total Assets | 3.13 | 3.42 | 2.9 | 2.41 | 2.33 | 2.79 |
Accounts Payable | 0.45 | 0.56 | 0.52 | 0.48 | 0.35 | 0.11 |
Accrued Expenses | - | - | 0.03 | 0.1 | 0.02 | 0.03 |
Current Unearned Revenue | 0.52 | 0.4 | 0.37 | 0.19 | 0.05 | - |
Other Current Liabilities | - | - | - | 0.25 | - | - |
Total Current Liabilities | 0.97 | 0.96 | 0.92 | 1.03 | 0.42 | 0.14 |
Total Liabilities | 0.97 | 0.96 | 0.92 | 1.03 | 0.42 | 0.14 |
Common Stock | 7.82 | 7.45 | 5.69 | 5.14 | 4.83 | 0.08 |
Additional Paid-In Capital | 0.99 | 0.91 | 0.86 | 0.38 | 0.38 | 0.14 |
Retained Earnings | -7.88 | -7.13 | -4.96 | -4.13 | -3.49 | -2.51 |
Comprehensive Income & Other | 1.23 | 1.23 | 0.38 | - | 0.19 | 4.94 |
Shareholders' Equity | 2.16 | 2.46 | 1.98 | 1.38 | 1.91 | 2.66 |
Total Liabilities & Equity | 3.13 | 3.42 | 2.9 | 2.41 | 2.33 | 2.79 |
Net Cash (Debt) | 0.58 | 0.96 | 0.42 | 0.2 | 0.85 | 2.47 |
Net Cash Growth | -61.75% | 129.07% | 115.02% | -77.11% | -65.53% | - |
Net Cash Per Share | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.08 |
Filing Date Shares Outstanding | 108.89 | 108.89 | 94.29 | 84.98 | 83 | 83 |
Total Common Shares Outstanding | 108.92 | 106.6 | 91.72 | 86.08 | 83 | 42.31 |
Working Capital | 0.41 | 0.69 | 0.13 | -0.32 | 0.66 | 2.39 |
Book Value Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 |
Tangible Book Value | 0.41 | 0.69 | 0.13 | -0.31 | 0.67 | 2.4 |
Tangible Book Value Per Share | 0.00 | 0.01 | 0.00 | -0.00 | 0.01 | 0.06 |
Machinery | - | - | - | 0.01 | 0.01 | 0 |